Abstract
Venous thromboembolism is one of the complications in patients prescribed antipsychotic medications. Neuroleptic malignant syndrome (NMS) is a rare side effect of antipsychotic medications in this population. In this case, a young patient, who presented with NMS after a recent start of antipsychotic medications, had developed a pulmonary embolism despite standard of care measures of venous thromboprophylaxis and early mobilization. A low threshold of VTE suspicion and effective preventive measures are both required in order to avoid this preventable complication in this population.
Highlights
S 226×109/L (150-450 ×109/L), and creatinine kinase 3792 U/L (30-300 U/L)
A young patient, who presented with Neuroleptic malignant syndrome (NMS) after a recent start ly of antipsychotic medications, had developed a pulmonary embolism despite stann dard of care measures of venous thromboo prophylaxis and early mobilization
It was first described in o 1960.1 NMS has been recognized and c described since that time especially with the - increasing use of antipsychotic medican tions
Summary
S 226×109/L (150-450 ×109/L), and creatinine kinase 3792 U/L (30-300 U/L). Serum electrolytes level, blood urea nitrogen, and creatinine were normal. Cial Introduction er Neuroleptic malignant syndrome (NMS) is a rare but serious psychiatric m emergency condition classically found in patients who have started taking antipsym chotic medications. It was first described in o 1960.1 NMS has been recognized and c described since that time especially with the - increasing use of antipsychotic medican tions. On day 3, he was oriented, communicating normally, and fully mobile with a gradual improvement in his creatinine kinase. He complained of one episode of a small amount of hemoptysis. Antipsychotic medications in the last two started atypical antipsychotic medications is years had a 32% higher risk of VTE comdescribed
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
